Rebekah Barnes

Turning the Tide in Lupus Treatment: Clinical Trials as Standard of Care

|

People living with lupus can have early access to innovative therapies alongside personalized support from a broader care team. How? Through participation in clinical trials.  Historically, clinical trial participation for lupus was discussed only after standard treatments failed the patient. Now, Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, is working to make … Turning the Tide in Lupus Treatment: Clinical Trials as Standard of Care

Lupus Clinical Research: A New Wave of Innovation 

|

A wave of lupus clinical research advances has been building over the past decade.  Now, it is reaching a crest.  A 2025 pipeline report identifies over 140 lupus therapies from 120+ companies now in clinical trials.i This surge of innovation is translating into potential treatments that are targeted, safer, and showing potential effectiveness for people living with lupus—offering more choices and options for treating the disease.  “This is … Lupus Clinical Research: A New Wave of Innovation 

Lupus Therapeutics Names Grantee for Groundbreaking IDEAL Initiative

|
Lupus Therapeutics Names Grantee for Groundbreaking IDEAL Initiative.

Imagine a future where everyday choices – like what people eat – could shape how lupus is treated and managed. That future may be closer than ever.   Earlier this year, Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, launched a pioneering initiative: Investigate Dietary Approaches for Lupus (IDEAL). It is the first-ever program … Lupus Therapeutics Names Grantee for Groundbreaking IDEAL Initiative